Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Placebo-Controlled, Phase 1, Single and Multiple IV Dose Escalation Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of C326 in Adults With Crohn's Disease

NCT00353756 is registered in ClinicalTrials.gov with Avidia as lead sponsor.

NCT NCT00353756
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00353756 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Placebo-Controlled, Phase 1, Single and Multiple IV Dose Escalation Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of C326 in Adults With Crohn's Disease
Lead sponsor
Avidia
Phase
Phase 1
Overall status
Unknown status
Start date
September 30, 2006
Completion date
September 30, 2007
Enrollment
52
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease